AIM To investigate the anti-inflammatory effect of intravitreal injection of anti-vascular
endothelial growth factor (anti-VEGF) in patients with macular edema secondary to retinal …

AIM To compare the efficacy of ranibizumab and bevacizumab for macular edema due to
retinal vein occlusion (RVO). METHODS A retrospective study was conducted at a single …

Purpose This study aimed to assess the short-term changes of macular microstructures
following anti-VEGF and anti-inflammatory therapies in patients with macular edema …

Purpose To evaluate the efficacy, safety, and injection frequency of vascular endothelial
growth factor (VEGF) antagonists in the treatment of macular edema secondary to retinal …

Abstract Background/Aims: To investigate the effects of intravitreal ranibizumab treatment for
macular edema (ME) secondary to retinal vein occlusion (RVO) and the relationship …

Purpose: To investigate aqueous humor levels of 11 factors/cytokines in patients with central
retinal vein occlusion (CRVO) and macular edema (ME) receiving anti-vascular endothelial …

Purpose To determine the correlation between aqueous humor cytokine levels and the
prognostic value of anti-vascular endothelial growth factor (VEGF) therapy for treating …

AIM To evaluate the efficacy and safety of combined anti-vascular endothelial growth factor
(VEGF) agents, oral glucocorticoid, and laser photocoagulation therapy for macular edema …

Purpose Report 5-year outcomes of patients receiving anti-vascular endothelial growth
factor (VEGF) for the treatment of macular oedema secondary to retinal vein occlusion (RVO …

PURPOSE: To determine the long-term effects of intraocular antagonism of vascular
endothelial growth factor (VEGF) in patients with macular edema caused by retinal vein …